Skip to content
Search

Latest Stories

Primary care networks play vital role in fighting Covid, report says

Primary care networks (PCNs) has played a significant role in combating the coronavirus pandemic in the UK, according to a report on the progress made and challenges faced by networks in the first two years of their five-year contract.

The report, based on a series of engagement sessions, hosted by the PCN Network, and a survey of more than 150 PCN clinical directors and PCN managers, was released by the NHS Confederation on Monday (2).


“Just two years on from their creation, they have risen to the challenges presented by the pandemic, administering the majority of vaccinations, reaching out to underserved communities and making headway against their objective to tackle health inequalities,” the report said.

Despite high workload during the pandemic PCNs’ profile has increased, leading to greater awareness of the services they offer and strengthening of relationships with local partners.

They helped in workforce development along with leadership capability and retention.

The report noted that PCNs are developing creative ways to reach underserved communities, tackle health inequalities and manage population health.

Highlighting the challenges faced by PCNs, the report said, “More than nine in ten survey respondents said their workload was greater than expected, with the consistently high workload derailing PCNs’ existing and planned work programmes.

“New service specifications are causing confusion over the purpose of PCNs, while a lack of consistent infrastructure was seen as hindering progress. Tensions were also identified with some local partners.”

A similar report on one-year performance of PCNs was released in July 2020, which identified three principles for NHS England and NHS Improvement (NHSEI) to consider when developing PCN policy.

The three principles were - PCNs having autonomy over their resources and influence over policies determining their future, as well as within integrated care systems (ICSs); a flexible approach to be factored into their development; and for the shift towards ICSs to be accompanied by streamlined processes for PCNs. These principles have informed PCN policy over the past year, especially with regards to the health and care bill and ICS guidance.

“We encourage NHSEI to use these principles to underpin the development of PCN policy and all policies that impact PCNs,” it said.

The 2021-22 network Direct Enhanced Services (DES) addressed some of the asks, that have not been resolved fully and remain relevant.

“Through continuing engagement with clinical directors and PCN managers, we will develop specific asks for the 2022-23 network contract DES in the autumn, relating to workload management; funding for PCN leadership and management; certainty around funding streams and contractual arrangements; and consistent and streamlined processes,” it said.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less